These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6200972)

  • 1. Migration patterns and functional activity of cloned cytotoxic T lymphocytes in syngeneic and allogeneic mice.
    LeFever AV; Truitt RL; Shih CC; Liepins A; Bortin MM
    Transplantation; 1984 Apr; 37(4):410-7. PubMed ID: 6200972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection.
    Byrne JA; Oldstone MB
    J Immunol; 1986 Jan; 136(2):698-704. PubMed ID: 2416821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivity of in-vitro-expanded alloimmune cytotoxic T lymphocytes and Qa-1-specific cytotoxic T lymphocytes against AKR leukemia in vivo.
    LeFever AV; Truitt RL; Shih CC
    Transplantation; 1985 Nov; 40(5):531-7. PubMed ID: 2414869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
    Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
    Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of CTL responses to alloantigens by a Db-specific T helper clone.
    Kwong PC; Kilburn DG; Teh HS
    J Immunol; 1984 Aug; 133(2):653-9. PubMed ID: 6203972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of primary cytotoxic T lymphocyte responses generated during mixed leukocyte culture with H-2d identical Qa-1-disparate cells.
    Huston DP; Tavana G; Rich RR; Gressens SE
    J Immunol; 1986 Sep; 137(6):1776-81. PubMed ID: 2943800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. II. Development of syngeneic cytotoxicity in the absence of specific antigenic stimulation.
    Claesson MH; Miller RG
    J Immunol; 1985 Feb; 134(2):684-90. PubMed ID: 2578160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of preferential cytotoxicity against allogeneic mouse lymphoma cells: in vitro and in vivo studies.
    Leshem B; Dorfman Y; Kedar E
    Cancer Immunol Immunother; 1999 Jul; 48(4):179-88. PubMed ID: 10431687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
    Plata F; Jongeneel V; Cerottini JC; Brunner KT
    Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
    Nahill SR; Welsh RM
    J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
    Hurrell SM; Zarling JM
    J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of T cell differentiation factor in syngeneic lymphocyte macrophage culture for cytotoxic T lymphocyte generation.
    Ting CC; Hargrove ME; Loh NN
    J Immunol; 1986 Mar; 136(5):1726-33. PubMed ID: 2936809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporary inhibition of Moloney-murine sarcoma virus (M-MSV) induced-tumours by adoptive transfer of ricin-treated T-lymphocytes.
    Cerundolo V; Zanovello P; McIntosh D; Fabbris R; Davies AJ; Collavo D
    Br J Cancer; 1987 Apr; 55(4):413-9. PubMed ID: 2437947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth-dependent variation of major histocompatibility complex (MHC) restriction and expression of Ly-2 and CD3/alpha/beta T cell receptor in cloned cytotoxic T cells.
    Weltzien HU; Kempkes B; Studer R; Melchers I; Eichmann K
    Eur J Immunol; 1988 Mar; 18(3):431-7. PubMed ID: 2965649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of cytotoxic T lymphocytes in vitro. VI. Effect of cell density on response in mixed leukocyte cultures.
    Fitch FW; Engers HD; MacDonald HR; Cerottini JC; Brunner KT
    J Immunol; 1975 Dec; 115(6):1688-94. PubMed ID: 127012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of factors regulating successful immunotherapy using a tumor-specific cytotoxic T lymphocyte clone: role of interleukin-2, cycling pattern of lytic activity and adhesion molecules.
    Hammond-McKibben DM; Seth A; Nagarkatti PS; Nagarkatti M
    Int J Cancer; 1995 Mar; 60(6):828-36. PubMed ID: 7896454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.